Benefit of High-flow Nasal Cannula on Persistent Dyspnea in Ild
ConditionILD
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssistance Publique - Hôpitaux de Paris
About this trial
The main purpose of this study is to evaluate the effects of high-flow nasal therapy (HFNT) oxygen compared to long-term oxygen therapy (LTOT) on dyspnea and quality of life in intersititial lung disease patients with chronic respiratory failure and persistent breathlessness in whom LTOT has already been initiated.
Eligibility criteria
Qualifiers
Intertitial lung disease
Persistant dyspnea (mMRC≥3)
Long-term oxygen therapy at least for 3 months
Disqualifiers
Chronic respiratory disease (COPD, lung cancer)
Pneumothorax,
Pneumomediastinum,
Active smoker,
Trial design
Treatments tested in this trial
- long-term oxygen therapy (LTOT)
- High Flow Nasal Therapy (HFNT)
Treatment groups
42 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov